How to Buy Immunocore Holdings Stock
Immunocore Holdings PLC
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
Immunocore Holdings stock last closed at $30.10, down 1.21% from the previous day, and has decreased 49.05% in one year. It has overperformed other stocks in the Biotechnology industry by 0.28 percentage points. Immunocore Holdings stock is currently +30.02% from its 52-week low of $23.15, and -52.02% from its 52-week high of $62.74.
There are currently 50.07M IMCR shares outstanding. The market capitalization of IMCR is $1.51B. In the last 24 hours, 127,183 IMCR shares were traded.
How to Buy Immunocore Holdings Stock
Wondering how to invest in Immunocore Holdings stock? Here's how.
- Figure out where to buy Immunocore Holdings stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Immunocore Holdings stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Select your method of payment and add your information.
- Analyze Immunocore Holdings stock: The Immunocore Holdings ticker symbol is IMCR. Is Immunocore Holdings stock a good investment? Should you buy shares of IMCR? How do IMCR's underlying business fundamentals look? Do top analysts think Immunocore Holdings is a good buy? Why has IMCR's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if IMCR is a good stock to buy).
- Make your IMCR buy order: Decide if you will purchase IMCR shares at the current market price or use a limit order to purchase IMCR shares at a particular price.
- Keep an eye on your IMCR investment: Create a watchlist to keep track of your investment in Immunocore Holdings shares.
Step 1: Figure out where to buy Immunocore Holdings stock
You will need a brokerage account in order to access the NASDAQ market and buy IMCR stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal information so you are able to buy IMCR stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open your new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on one of the most highly reviewed stock market apps, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help depositing funds into your investment account.
Step 4: Analyze Immunocore Holdings stock
After you have decided on the best place to buy Immunocore Holdings stock, it's important to evaluate their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Immunocore Holdings stock quick numbers
IMCR Due Diligence Score
WallStreetZen was built to help average investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on IMCR's stock page.
Is IMCR stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge IMCR's intrinsic value.
Using relative valuations measures:
- IMCR could be undervalued based on its P/B ratio of 4.18x, relative to Biotechnology industry P/B ratio of 4.45x
You can do additional valuation research on IMCR's stock here.
IMCR Financials at a glance
Signs that IMCR is financially healthy:
- There are more short-term assets than short-term liabilities on the IMCR balance sheet.
- Total IMCR debt is lower than 5 years ago, relative to shareholder equity.
- IMCR profit margin has gone up from -22.2% to -16.5% in the past year.
- There are more short-term assets than long-term liabilities on the IMCR balance sheet.
Signs that IMCR is not financially healthy:
- IMCR has a relatively high debt to equity ratio of 1.8.
- IMCR's operating cash flow of $26.06M allows it to safely service it's debt of $432.72M.
- IMCR earnings of -$34.09M is not sufficient to cover its interest payments.
Is it a good time to buy Immunocore Holdings stock, according to Wall Street analysts?
Out of 5 sell side analysts who track IMCR, the consensus analyst rating on Immunocore Holdings is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Immunocore Holdings stock forecast page.
IMCR Technical Indicators
IMCR Growth Numbers
Last year, IMCR revenue was $310.20M. Over the past 5 year, IMCR's revenue has grown by 57.42% per year. This was faster than the Biotechnology industry average of 45.66%.
Dive into IMCR's earnings and revenue performance here.
Are IMCR executives and large shareholders buying or selling the stock?
Over the past 12 months, insiders at IMCR have bought more shares than they have sold.
Baker Bros Advisors LP, Director of IMCR, was the latest IMCR insider to buy. They bought $1,787,791.62 worth of IMCR stock on Mar 17, 2025.
Dig into more about who owns IMCR stock here.
Does IMCR provide a stable income stream?
No, Immunocore Holdings doesn't provide an income stream by paying out dividends.
IMCR Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your IMCR buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, use a limit order.
Press the Open Trade button and eToro will execute your order.
If you want additional help investing in stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your IMCR investment
Now that you own some shares in IMCR, you'll want to keep up with your investment.
Add IMCR to a watchlist to get notified of important updates regarding your IMCR stock.
IMCR Feed
How to Buy Stock in Immunocore Holdings
To summarize, here are the 6 steps to buy stock in Immunocore Holdings:
- Figure out where to buy Immunocore Holdings stock
- Open a brokerage account
- Deposit funds into your investment account
- Analyze Immunocore Holdings stock
- Make your IMCR buy order
- Keep an eye on your IMCR investment
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest news on your new investment in Immunocore Holdings, click the button below.
Other Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.